Publication: 640

Publication: 640

NCCTG phase II trial of bevacizumab in combination with sorafenib (BEV/SOR) in recurrent glioblastoma (RGBM).

URL

Google Scholar

Citation:: Neuro-oncology vol 13 (3) 62 Abstract NO-93

Meeting Instance:: SNO 2011
Year:: 2011
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 1040

Program:: OGC
Primary Committee:: Neuro-Onc
Sec. Committees:

Pharmas:
Grants:

Corr. Author:
Authors:: E. Galanis S. K. Anderson J. M. Lafky T. J. Kaufmann J. H. Uhm C. Giannini S. K. Kumar D. W. Northfelt P. J. Flynn K. A. Jaeckle J. C. Buckner

Networks:

Study: NCCTG-N0776
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: